Firms

EcoR1 Capital
San Francisco, California, United States
San Francisco biotechnology investment advisory firm founded by Oleg Nodelman. It invests in companies across stages of research and development, combining scientific evaluation with investment analysis. Its published venture portfolio includes AI-enabled drug discovery, computational biotechnology, cell and gene therapies, and companies developing treatments for neurological disorders.
- Founded
- 2013
- Type
- Venture capital
Funds0
No funds on record yet.
Team
Operations and support
Areesha SaifAnalyst |
Basheer ZadaPrincipal |
Caroline ChoExecutive Personal Assistant |
Caroline StoutPartner |
Daniel ChizhikovAnalyst |
Daniel RodriguezCounsel |
Geoff KeoughTrader |
Maddie GehrichInvestor Relations Associate |
Miranda FornaroOperations Manager |
Nima EmamiAnalyst |
Oleg KhusainovController |
Oleg NodelmanFounder and Portfolio Manager |
Sarah MarriottPartner, Chief Operating Officer, General Counsel and Chief Compliance Officer |
Scott PerlenChief Financial Officer |
Whan LeeSenior Analyst |
Co-investing
Samsara BioCapital
Neurogene$200M · 2024-11-04
Neurogene$95M · 2023-12-18
Dewpoint Therapeutics$150M · 2022-02-03
Neurogene$115M · 2020-12-16
Dewpoint Therapeutics$77M · 2020-09-29
Neurogene$68M · 2019-02-12
Dewpoint Therapeutics$60M · 2019-01-30
Janus Henderson Investors
Immunic$200M · 2026-02-17
CAMP4 Therapeutics$30M · 2025-12-18
Neurogene$95M · 2023-12-18
Neurogene$115M · 2020-12-16
Alexandria Venture Investments
Neurogene$95M · 2023-12-18
Neurogene$115M · 2020-12-16
Dewpoint Therapeutics$60M · 2019-01-30
Leaps by Bayer
Dewpoint Therapeutics$150M · 2022-02-03
Dewpoint Therapeutics$77M · 2020-09-29
Dewpoint Therapeutics$60M · 2019-01-30
Polaris Partners
Dewpoint Therapeutics$150M · 2022-02-03
Dewpoint Therapeutics$77M · 2020-09-29
Dewpoint Therapeutics$60M · 2019-01-30
ARCH Venture Partners
Dewpoint Therapeutics$150M · 2022-02-03
Dewpoint Therapeutics$77M · 2020-09-29
Maverick Ventures
Dewpoint Therapeutics$150M · 2022-02-03
Dewpoint Therapeutics$77M · 2020-09-29
Trails Edge Capital Partners
Immunic$200M · 2026-02-17
CAMP4 Therapeutics$30M · 2025-12-18
Vivo Capital
Immunic$200M · 2026-02-17
CAMP4 Therapeutics$30M · 2025-12-18
3E Bioventures Capital
Dewpoint Therapeutics$150M · 2022-02-03
6 Dimensions Capital
Dewpoint Therapeutics$60M · 2019-01-30
BECO Capital
Dewpoint Therapeutics$150M · 2022-02-03
BVF Partners L.P.
Immunic$200M · 2026-02-17
Commodore Capital
Neurogene$200M · 2024-11-04
Elena Viboch
Dewpoint Therapeutics$150M · 2022-02-03
General Catalyst
Dewpoint Therapeutics$150M · 2022-02-03
Innovation Endeavors
Dewpoint Therapeutics$77M · 2020-09-29
Mirae Asset Capital
Dewpoint Therapeutics$150M · 2022-02-03
Mubadala Capital
Dewpoint Therapeutics$150M · 2022-02-03
NS Investment
Dewpoint Therapeutics$150M · 2022-02-03
RA Capital Management
Immunic$200M · 2026-02-17
RTW Investments, LP
Neurogene$200M · 2024-11-04
SoftBank Vision Fund 2
Dewpoint Therapeutics$150M · 2022-02-03
Woodline Partners
Immunic$200M · 2026-02-17






























